Department of Medicinal Chemistry professor Dave Ferguson was awarded a $30,000 Randy Shaver Cancer Research Fund, with co-PIs from Pharmaceutics and Urologic Surgery, for "An Advanced Vaccine for Treating Bladder Cancer."
He is also co-investigator on a $200,000 AHC Faculty Research Development grant for
the project "Enhancing Cancer Immunotherapy by Combined Nonsense
Mediated Decay Inhibition and Premature Stop Codon Suppression to Enable
Tumor Neoantigen Expression."
